FDA pushes back review deadline for Theratechnologies' tesamorelin

02/25/2010 | Reuters

The FDA postponed its deadline for reviewing Theratechnologies' drug tesamorelin to July 27 after a panel meeting was moved to May 27. The drugmaker submitted tesamorelin for approval to treat excess abdominal fat in HIV-positive patients.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN